Similarly, the absence of VEGFC/VEGFR3 signaling in mouse models of cardiac hypertrophy increases cardiac hypertrophy and dysfunction, while VEGFC transmission improves hypertrophy and delays the development of centripetal heart failure [151]. Here, VEGFC is linked to hypertrophy.